KNTE

Q: What is the price of Kinnate Biopharma (KNTE) today?

The price of Kinnate Biopharma (KNTE) today is $ 0.00, with return of 0% compared to the last year. The price of Kinnate Biopharma (KNTE) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Kinnate Biopharma (KNTE) and international markets.

Q: When does Kinnate Biopharma (KNTE) pay dividends?

Kinnate Biopharma (KNTE) did not distribute dividends in the last year.

Q: Is Kinnate Biopharma (KNTE) worth it?

Currently, Kinnate Biopharma (KNTE) is priced at $ 0.00, with a P/E of -1.13%, representing a deviation of -187% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Kinnate Biopharma (KNTE) stock?

Investing in stocks of Kinnate Biopharma (KNTE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Kinnate Biopharma (KNTE) yield today?

The yield of Kinnate Biopharma (KNTE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Kinnate Biopharma (KNTE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Kinnate Biopharma Inc.

Price

$ -

return (12m)

0.00%

p/e

-1.13

p/bv

0.78

DIVIDEND YIELD

0.00%

KNTE price

KNTE

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment KNTE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals KNTE

review the fundamentals of Kinnate Biopharma shares

P/E

-1.13

Sector: 9.06 Industry: 43.81

P/S (PSR)

Sector: 0.84 Industry: 3.13

P/BV

0.78

Sector: 1.52 Industry: 12.97

DIVIDEND YIELD (DY)

0.00%

Sector: 0.38% Industry: 1.64%

ROA

-63.62%

Sector: 0.15% Industry: 9.49%

ROE

-69.32%

Sector: 0.51% Industry: 29.59%

ROIC

-363.92%

Sector: -5.99% Industry: 18.19%

NET MARGIN

0.00%

Sector: 0.59% Industry: 10.83%

GROSS MARGIN

0.00%

Sector: 36.79% Industry: 50.29%

OPERATING MARGIN

0.00%

Sector: 4.85% Industry: 11.16%

EV/EBITDA

-1.06

Sector: 4.54 Industry: 22.90

EV/EBIT

-1.06

Sector: 5.27 Industry: 29.14

PRICE-TO-ASSETS

0.72

Sector: 0.66 Industry: 2.75

BVPS

3.39

Sector: 9.50 Industry: 132.31

EPS

-2.35

Sector: 0.46 Industry: 39.16

EQUITY-TO-ASSETS RATIO

0.92

Sector: 0.28 Industry: 0.59

LIABILITIES / ASSETS

0.92

Sector: 0.54 Industry: 0.84

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

4.65%

Sector: - Industry: -

Fundamentals KNTE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AMZN	28.92	5.46	18.89%	0.00%	$ 2.25 T	10.83%
MELI	43.81	12.97	29.59%	0.00%	$ 87.49 B	6.91%
DIS	13.97	1.50	10.75%	1.30%	$ 171.15 B	12.80%
VZ	12.17	1.98	16.24%	5.54%	$ 208.96 B	12.43%
MCD	25.54	-122.10	-478.11%	2.36%	$ 218.68 B	31.85%
WMT	45.80	9.44	20.62%	0.95%	$ 1.00 T	3.07%
V	27.68	14.84	53.62%	0.84%	$ 575.43 B	50.23%
COST	52.71	14.04	26.64%	0.51%	$ 450.64 B	2.99%
NFLX	38.00	15.68	41.26%	0.00%	$ 417.23 B	24.30%
BABA	22.36	1.80	8.07%	1.64%	$ 283.28 B	8.90%
T	9.16	1.56	17.09%	3.92%	$ 201.09 B	17.47%
SBUX	75.19	-12.28	-16.33%	2.72%	$ 102.93 B	3.63%
HD	22.56	24.93	110.48%	2.87%	$ 319.38 B	8.60%
TGT	14.58	3.34	22.93%	3.81%	$ 54.04 B	3.54%
CMCSA	5.09	1.05	20.54%	4.73%	$ 101.78 B	16.17%
TBB	11.68	1.46	12.50%	5.61%	$ 171.43 B	11.99%
CMG	28.39	15.40	54.26%	0.00%	$ 43.61 B	12.88%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

KNTE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kinnate Biopharma

Kinnate Biopharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

8 years

Founded: 2018

2020

Time since IPO - 6 years

31

Employees

The Company Kinnate Biopharma Inc. (United States), is listed on Nasdaq with a market value of $ 124.55 Millions, having an equity of $ 159.33 Millions.

With a total of 31 employees, the company is listed in the sector of Services and categorized in industry of Commercial Services.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -112.65 Millions.

As for its main indicators, the Company has a P/E ratio of -1.13, a P/BV ratio of 0.78 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker KNTE.

Market cap

$ 124.55 Millions

Net worth

$ 159.33 Millions

US$ 159,330,000.00

Assets

$ 173.60 Millions

US$ 173,600,000.00

Total Shares Outstanding

47.00 Millions

47,000,000

Average Daily Trading Volume

$ 480.75 Thousand

US$ 480,748.78

Sector

Services

Industry

Commercial Services

KNTE

KNTE revenue and profits

Financial Results KNTE

DRAG THE FRAME TO SEE MORE DATA

KNTE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

WSG - Wanda Sports Group

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-7.74%

P/BV

0.00

AMZN - Amazon

$ 209.77 19,69% (12M)

P/E

28.92

0.00%

ROE

18.89%

P/BV

5.46

WMT - Walmart

$ 125.79 53,89% (12M)

P/E

45.80

0.95%

ROE

20.62%

P/BV

9.44

COST - Costco Wholesale

$ 1,014.96 11,35% (12M)

P/E

52.71

0.51%

ROE

26.64%

P/BV

14.04

JD - JD.com

$ 28.46 --17,72% (12M)

P/E

15.30

3.31%

ROE

6.52%

P/BV

1.00

BABA - Alibaba

$ 122.05 4,73% (12M)

P/E

22.36

1.64%

ROE

8.07%

P/BV

1.80

WBA - Walgreens Boots Alliance

$ - -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

HD - Home Depot

$ 321.63 --6,82% (12M)

P/E

22.56

2.87%

ROE

110.48%

P/BV

24.93

WSG - Wanda Sports Group

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-7.74%

P/VP

0.00

AMZN - Amazon

$ 209.77 19,69% (12 M)

P/L

28.92

0.00%

ROE

18.89%

P/VP

5.46

WMT - Walmart

$ 125.79 53,89% (12 M)

P/L

45.80

0.95%

ROE

20.62%

P/VP

9.44

COST - Costco Wholesale

$ 1,014.96 11,35% (12 M)

P/L

52.71

0.51%

ROE

26.64%

P/VP

14.04

JD - JD.com

$ 28.46 --17,72% (12 M)

P/L

15.30

3.31%

ROE

6.52%

P/VP

1.00

BABA - Alibaba

$ 122.05 4,73% (12 M)

P/L

22.36

1.64%

ROE

8.07%

P/VP

1.80

WBA - Walgreens Boots Alliance

$ - -0,00% (12 M)

P/L

-1.76

4.17%

ROE

-80.35%

P/VP

1.42

HD - Home Depot

$ 321.63 --6,82% (12 M)

P/L

22.56

2.87%

ROE

110.48%

P/VP

24.93

Frequently Asked Questions

What is the price of Kinnate Biopharma (KNTE) today?

The price of Kinnate Biopharma (KNTE) today is $ 0.00, with return of 0% compared to the last year. The price of Kinnate Biopharma (KNTE) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Kinnate Biopharma (KNTE) and international markets.

When does Kinnate Biopharma (KNTE) pay dividends?

Kinnate Biopharma (KNTE) did not distribute dividends in the last year.

Is Kinnate Biopharma (KNTE) worth it?

Currently, Kinnate Biopharma (KNTE) is priced at $ 0.00, with a P/E of -1.13%, representing a deviation of -187% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Kinnate Biopharma (KNTE) stock?

Investing in stocks of Kinnate Biopharma (KNTE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Kinnate Biopharma (KNTE) yield today?

The yield of Kinnate Biopharma (KNTE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Kinnate Biopharma (KNTE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

KNTE

Kinnate Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KNTE

review the fundamentals of Kinnate Biopharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kinnate Biopharma

Kinnate Biopharma Inc.

United States

8 years

2020

31

PROFIT X PRICE KNTE

Financial Results KNTE

KNTE cash flow

Asset, Revenue and Profit Growth - KNTE

KNTE balance sheet

WSG - Wanda Sports Group

AMZN - Amazon

WMT - Walmart

COST - Costco Wholesale

JD - JD.com

BABA - Alibaba

WBA - Walgreens Boots Alliance

HD - Home Depot

WSG - Wanda Sports Group

AMZN - Amazon

WMT - Walmart

COST - Costco Wholesale

JD - JD.com

BABA - Alibaba

WBA - Walgreens Boots Alliance

HD - Home Depot

Frequently Asked Questions